Dealmaker’s Diary: Add This Undervalued Retail Pioneer to Your Cart
This bulk retail pioneer has been serving up jumbo-sized gains over the past few years. Get the ticker here.
Buy This, Not That: Put These Controversial Stocks on Your “Buy” List
It doesn’t matter what they do or where they do it. Are they making money? These five Chinese stocks are.
Monday Takeaways: The Magnificent Seven’s Creative Destruction
Barron’s is out with a piece that suggests it’s time to get out of the Magnificent Seven. Here’s why that’s wrong.
Buy This, Not That: Summer Sizzlers and Vacation Busts
As summer travel kicks into high gear, here are six travel and leisure stocks that should be either added to your bucket list… or be given one-star reviews.
Monday Takeaways: All Is Not Quiet on Wall Street
It should be a quiet holiday week on Wall Street… but investors need to watch out. Here’s why…
Dealmaker’s Diary: A $3B Unsung Hero of the Corporate World
This stable and boring company keeps corporate America running… and its stock is primed for a July breakout.
Buy This, Not That: Are These Stocks Dressed for Success?
We’re diving into the closets of America’s biggest clothing retailers… to see which of these five stocks are the right fit for your portfolio.
Monday Takeaways: $323 Billion Up for Grabs
There’s $323 billion up for grabs in the Treasury market. Whether the auctions go well or not… will tell us more about where interest rates and the markets are headed.
Buy This, Not That: Your Mid-Year “Magnificent 7” Investing Guide
They’re the titans of tech, the juggernauts of the market. Some are as sizzling as a summer heat wave… and others need to be put on ice. Find out which is which here…
Dealmaker’s Diary: This Biotech Is Fighting a Silent Killer
Chronic and life-threatening diseases are on the rise… But one company stands tall in the fight against a silent killer: pulmonary arterial hypertension.